Prophylactic Thoracic Duct Mass Ligation Prevents Chylothorax After Transthoracic Esophagectomy for Cancer
Matteo Cagol(Istituto Oncologico Veneto), Ermanno Ancona(University of Padua), Alberto Ruol(University of Padua), Silvia Michieletto(Istituto Oncologico Veneto), Rita Alfieri(Istituto Oncologico Veneto), Carlo Castoro(Humanitas University)
Cited by 56
Related Papers
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
|Annals of Surgical Oncology|2022|162
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
|npj Breast Cancer|2021|100
Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
|Journal of Gastrointestinal Surgery|2013|95
Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Squamous Cell Carcinoma of the Thoracic Esophagus
|Annals of Surgery|2010|74
Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer
|Annals of Surgery|2021|67